Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

48 results about "Ibuprofen Injection" patented technology

A formulation for intravenous injection containing ibuprofen, a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID), with anti-inflammatory, analgesic, and antipyretic activities. Upon intravenous injection, ibuprofen inhibits the activity of the enzymes cyclooxygenase I (COX-1) and II (COX-2), resulting in a decreased formation of precursors of prostaglandins and thromboxanes. Inhibition of COX-2 specifically blocks the conversion of arachidonic acid (AA) to prostaglandins, which mediate inflammation, fever and pain.

Ibuprofen injection preparation and preparation method thereof

The invention relates to an ibuprofen injection preparation and a preparation method thereof, and especially relates to an ibuprofen injection preparation with meglumine as a cosolvent and a preparation method thereof, wherein the molar ratio of meglumine and ibuprofen is 0.1-2.0:1. The invention provides a new effective method which allows ibuprofen to be dissolved, the drug effect of ibuprofen to be rapidly and fully performed, and the solution formed by ibuprofen to be used for preparing a solution for injection or freeze-dried powder for injection. By carrying out pharmic stability tests,animal safety tests, pharmacokinetics and the like to realize the multitime investigation of the stability, the safety and the effectiveness of the ibuprofen injection preparation, results show that the ibuprofen injection preparation has a strong stability. So compared with the prior part, the preparation method of the invention allows the safety and the effectiveness of drugs to be guaranteed.
Owner:SICHUAN KELUN PHARMA RES INST CO LTD

Ibuprofen injection

The invention provides an ibuprofen injection which includes ibuprofen, solubilizer and injection water.Solubilizer is selected from disodium hydrogen phosphate, dipotassium phosphate, sodium dihydrogen phosphate, monopotassium phosphate or any combination of disodium hydrogen phosphate, dipotassium phosphate, sodium dihydrogen phosphate and monopotassium phosphate and can also be selected from sodium phosphate, potassium phosphate or combination of sodium phosphate and potassium phosphate.Ibuprofen has concentration of 1-6 mg / ml and preferentially 2-4 mg / ml.The ibuprofen injection is high in stability in the transportation process, and the quality of a compatible product is not influenced in the clinical compatibility use process.
Owner:BEIJING LANDAN PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products